Press-release for stocks related to merge for pfe

| -49.68% | O: 0.56% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -7.77% | O: 0.82% H: 0.0% C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K

| -39.27% | O: 1.63% H: 11.55% C: 11.21%
covid-19 covid authorization vaccine tiona merge order emergency use authorization

Investor Alert: The M&A Class Action Firm Continues Investigating the Merger - VG, TACO, ARNA, UMPQ, LEVL, NES
Published: 2022-01-15 (Crawled : 08:20) - prnewswire.com
BOX 4 | $27.28 -0.07% -0.07% 1.1M

Technology Services

| Email alert Add to watchlist
COLB F | $19.2 0.63% 0.63% 1.8M

| Email alert Add to watchlist
WTTR | News | $9.36 -0.32% 0.0% 980K

Industrial Services

| Email alert Add to watchlist
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| Email alert Add to watchlist
ERIC | News | $5.285 -1.4% -1.42% 22M

Electronic Technology

| Email alert Add to watchlist
VG | $20.99 0.0%

| Email alert Add to watchlist
merge

Breast Cancer Treatment Advancements Emerge After New Study Finds Global Deaths Increased in 2019
Published: 2022-01-14 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K

| 15.49% | O: -0.21% H: 0.98% C: 0.98%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| -52.7% | O: -1.01% H: 0.0% C: 0.0%
ONCY | $1.045 -3.24% -3.35% 180K

| -28.57% | O: 0.65% H: 0.0% C: 0.0%
INCY | $51.72 0.14% 0.14% 1.5M

| -29.75% | O: 0.0% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 22.55% | O: 0.17% H: 0.0% C: 0.0%
treatment cancer breast cancer merge

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older
Published: 2022-01-03 (Crawled : 18:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

| -5.05% | O: -0.47% H: 0.0% C: 0.0%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| -55.51% | O: -0.93% H: 0.09% C: -3.16%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -5.3% | O: 1.16% H: 0.0% C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K

| -65.83% | O: -1.52% H: 0.89% C: -8.67%
covid-19 fda als covid authorization vaccine merge order emergency use authorization

Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment
Published: 2021-12-22 (Crawled : 20:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| -55.44% | O: 0.51% H: 2.25% C: 0.51%
covid-19 treatment fda covid authorization antiviral merge emergency use authorization

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older
Published: 2021-12-09 (Crawled : 18:00) - globenewswire.com
FNCTF | News | $11.16 -20.84% 130

| 9.3% | O: 0.69% H: 0.68% C: 0.68%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| -48.89% | O: 0.23% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -1.51% | O: -0.85% H: 0.0% C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K

| -71.49% | O: -3.53% H: 0.32% C: -4.65%
covid-19 fda covid authorization vaccine merge order emergency use authorization

Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older
Published: 2021-11-19 (Crawled : 13:30) - globenewswire.com
FNCTF | News | $11.16 -20.84% 130

| -0.53% | O: -2.67% H: 0.45% C: 0.45%
SNYNF | News | $94.25 -2.18% 480

| -4.28% | O: 3.28% H: 0.0% C: 0.0%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| -48.9% | O: 0.84% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -5.43% | O: 0.4% H: 0.0% C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K

| -67.86% | O: 1.58% H: 0.0% C: 0.0%
covid fda vaccine merge order emergency use authorization

Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine in Children Ages 5 Through 11 Years
Published: 2021-10-29 (Crawled : 22:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480

| Email alert Add to watchlist
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| Email alert Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M

| Email alert Add to watchlist
FNCTF | News | $11.16 -20.84% 130

| Email alert Add to watchlist
BNTX | News | $88.18 -0.35% -0.35% 280K

| Email alert Add to watchlist
covid fda children vaccine merge emergency use authorization

FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech Covid-19 Vaccine in Children 5 to <12 Years
Published: 2021-10-26 (Crawled : 23:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| -39.32% | O: 0.39% H: 0.23% C: -1.13%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -4.42% | O: 0.91% H: 0.06% C: -1.04%
BNTX | News | $88.18 -0.35% -0.35% 280K

| -70.21% | O: -0.4% H: 1.16% C: -5.35%
covid fda children vaccine merge emergency use authorization

FDA Advisory Committee Votes Unanimously in Favor of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-Risk Populations
Published: 2021-09-18 (Crawled : 08:20) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M

| Email alert Add to watchlist
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| Email alert Add to watchlist
BNTX | News | $88.18 -0.35% -0.35% 280K

| Email alert Add to watchlist
fda risk merge comirnaty® order

Alpha Healthcare and Humacyte Announce Nominees for Election to Post-Merger Public Company Board of Directors
Published: 2021-08-13 (Crawled : 12:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| -44.39% | O: 0.55% H: 0.0% C: 0.0%
MYOV | $26.98 -0.04% 0.0% 0

| 22.25% | O: 0.27% H: 0.0% C: 0.0%
MS | News | $93.85 0.1% 0.0% 4.8M

| -10.34% | O: -0.11% H: 0.0% C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

| -15.45% | O: -0.09% H: 0.0% C: 0.0%
F | News | $12.95 0.08% 2.55% 74M

Consumer Durables

| -6.83% | O: 0.04% H: 0.0% C: 0.0%
CS | $0.8858 1.49% 64M

| -91.51% | O: -0.34% H: 0.0% C: 0.0%
EXAS | $63.24 -0.46% -0.46% 1.2M

| -34.35% | O: 1.64% H: 0.0% C: 0.0%
DMTK 4 | $0.616 3.81% 72K

| -98.36% | O: 0.86% H: 0.0% C: 0.0%
NMTR | $0.0722 -42.97% -67.9% 10M

| -93.19% | O: -0.94% H: 0.0% C: 0.0%
merge

Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
Published: 2021-05-11 (Crawled : 07:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| -34.09% | O: -0.45% H: 0.98% C: -0.83%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -9.54% | O: -1.47% H: 0.7% C: 0.52%
BNTX | News | $88.18 -0.35% -0.35% 280K

| -56.47% | O: -7.78% H: 8.52% C: 6.11%
covid vaccine merge authorized covid-19

Global Active Pharmaceutical Ingredient (API) Market Report 2021-2025: Opportunities in Advancements in API Manufacturing, Growth in the CMOs, & Emergence of Biosimilars Market
Published: 2021-05-10 (Crawled : 12:15) - prnewswire.com
VTRS | News A | $11.55 1.67% 1.65% 7.2M

| -17.97% | O: 6.39% H: 3.3% C: 0.4%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| -33.63% | O: 0.63% H: 1.13% C: 0.08%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 11.81% | O: 0.05% H: 0.37% C: -0.02%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 6.54% | O: 0.76% H: 0.27% C: -0.28%
LLY | News | $732.2 -1.81% 0.18% 2.1M

| 284.92% | O: 0.38% H: 0.22% C: -0.72%
BMY | $48.86 -0.27% -0.02% 16M

| -24.18% | O: 0.31% H: 1.01% C: 0.09%
ALB | News | $115.27 0.93% -0.23% 2.2M

Process Industries

| -29.16% | O: 0.41% H: 1.07% C: -2.39%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -8.44% | O: 1.54% H: 0.17% C: -0.32%
cmo growth merge biosimilar

Global Cell and Gene Therapy Market Report 2021-2027: Market Opportunities in Drug Approvals and Strong Pipeline & Increasing Number of Mergers and Acquisitions
Published: 2021-03-08 (Crawled : 13:14) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| -23.61% | O: 0.26% H: 1.13% C: -0.38%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 17.07% | O: -0.02% H: 0.89% C: -0.31%
ORGO | $2.99 0.34% 0.33% 2.5M

| -80.25% | O: 1.86% H: 1.82% C: -2.21%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| 19.88% | O: 0.15% H: 1.81% C: -0.12%
acquisition gene therapy therapy acquisitions drug merge approval gene therapies

Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.
Published: 2020-12-10 (Crawled : 00:01) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M

| -37.05% | O: 0.58% H: 0.24% C: -2.03%
BNTX | News | $88.18 -0.35% -0.35% 280K